We are live on ! Find out more
Daiwa Securities Group

Daiwa Securities Group Portfolio holdings

AUM $34.8B
1-Year Est. Return 20.7%
This Fund
S&P 500
This Quarter Est. Return
-4.66%
1 Year Est. Return
+20.7%
3 Year Est. Return
+66.64%
5 Year Est. Return
+79.21%
10 Year Est. Return
+192.59%
AUM
$12.5B
AUM Growth
-$1.66B
Cap. Flow
-$1.45B
Cap. Flow %
-11.6%
Top 10 Hldgs %
32.88%
Holding
1,206
New
194
Increased
593
Reduced
261
Closed
41

Sector Composition

Rank Sector Weight
1 Real Estate 73.13%
2 Industrials 4.58%
3 Technology 4.24%
4 Financials 3.1%
5 Healthcare 2.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AKCA
1026
DELISTED
Akcea Therapeutics Inc
AKCA
$9K ﹤0.01%
+368
New +$7.92K
ATRA icon
1027
Atara Biotherapeutics
ATRA
$69.5M
$8K ﹤0.01%
+8
New +$7.29K
DBC icon
1028
Invesco DB Commodity Index Tracking Fund
DBC
$1.67B
$8K ﹤0.01%
500
EDIT icon
1029
Editas Medicine
EDIT
$411M
$8K ﹤0.01%
+233
New +$8.3K
ENTA icon
1030
Enanta Pharmaceuticals
ENTA
$370M
$8K ﹤0.01%
+105
New +$8.08K
PRTA icon
1031
Prothena Corp
PRTA
$455M
$8K ﹤0.01%
+212
New +$7.71K
XNCR icon
1032
Xencor
XNCR
$1.47B
$8K ﹤0.01%
+260
New +$6.8K
IMGN
1033
DELISTED
Immunogen Inc
IMGN
$8K ﹤0.01%
+731
New +$7.22K
MNTA
1034
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
$8K ﹤0.01%
+422
New +$7.04K
EOCC
1035
DELISTED
Enel Generacion Chile S.A.
EOCC
$8K ﹤0.01%
350
-900
-72% -$25.1K
ZGNX
1036
DELISTED
Zogenix, Inc.
ZGNX
$8K ﹤0.01%
+189
New +$7.5K
FL
1037
DELISTED
Foot Locker
FL
$7K ﹤0.01%
152
+127
+508% +$5.91K
IOVA icon
1038
Iovance Biotherapeutics
IOVA
$2.19B
$7K ﹤0.01%
+401
New +$6.07K
MEDP icon
1039
Medpace
MEDP
$16.5B
$7K ﹤0.01%
+208
New +$7.6K
PCRX icon
1040
Pacira BioSciences
PCRX
$1.04B
$7K ﹤0.01%
+224
New +$7.98K
TBPH icon
1041
Theravance Biopharma
TBPH
$874M
$7K ﹤0.01%
+299
New +$8.21K
ENDP
1042
DELISTED
Endo International plc
ENDP
$7K ﹤0.01%
+1,234
New +$8.63K
EPZM
1043
DELISTED
Epizyme, Inc
EPZM
$7K ﹤0.01%
+383
New +$6.47K
CTMX icon
1044
CytomX Therapeutics
CTMX
$708M
$6K ﹤0.01%
+212
New +$6.05K
LKFT
1045
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.84B
$6K ﹤0.01%
+60
New +$6.47K
PTCT icon
1046
PTC Therapeutics
PTCT
$6.29B
$6K ﹤0.01%
+229
New +$5.8K
TXMD icon
1047
TherapeuticsMD
TXMD
$24M
$6K ﹤0.01%
+24
New +$6.73K
ITCI
1048
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$6K ﹤0.01%
+302
New +$5.88K
RVNC
1049
DELISTED
Revance Therapeutics, Inc.
RVNC
$6K ﹤0.01%
+202
New +$6.5K
GTHX
1050
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
$6K ﹤0.01%
+157
New +$4.19K

Similar funds

Daiwa Securities Group's Q1 2018 Portfolio in Review

As of Q1 2018, Daiwa Securities Group held 1,206 positions worth $12.5B, down 12% from $14.1B the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Daiwa Securities Group withdrew a net $1.45B in Q1 2018, closing 41 positions and reducing 261 holdings. Its most notable exit was Anthem, Inc., an estimated $25.2M position sold in full.

By sector, the portfolio is most concentrated in Real Estate at 73% of assets, down from 77% a quarter earlier, followed by Industrials and Technology.

Against the trend, Daiwa Securities Group opened a new position in Supernus Pharmaceuticals worth $3.16M.

  • Daiwa Securities Group's largest Q1 2018 buy was Supernus Pharmaceuticals: 68,983 shares worth $3.16M.
  • Daiwa Securities Group added most to Boston Properties in Q1 2018, an estimated $165M increase.
  • Daiwa Securities Group's biggest Q1 2018 reduction was Simon Property Group, cutting an estimated $275M.
  • Daiwa Securities Group fully exited Anthem, Inc. in Q1 2018, selling an estimated $25.2M.
  • Daiwa Securities Group's ten largest holdings make up 33% of its $12.5B portfolio in Q1 2018.
  • Daiwa Securities Group opened 194 new positions and closed 41 in Q1 2018.
  • Daiwa Securities Group's portfolio value fell 12% quarter-over-quarter to $12.5B.

Based on Daiwa Securities Group's 13F filing for Q1 2018, filed 2 May 2018.